Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Iron cation" refers generally to the ionic forms of iron found in biology and chemistry, most commonly the divalent iron (Fe²⁺, ferrous) and trivalent iron (Fe³⁺, ferric) ions[1][7][10]. These ions are not specific receptors, enzymes, or molecular targets but rather fundamental redox-active species participating in many biochemical processes, including oxygen transport (as part of hemoglobin and myoglobin), electron transport (cytochromes), DNA synthesis, and numerous enzymatic reactions[2][5][6][8]. Iron homeostasis is tightly regulated through a complex interplay of cellular importers/exporters (such as transferrin receptor, ferroportin), storage proteins (ferritin), and regulatory molecules (hepcidin, iron regulatory proteins)[2][5][8]. Clinical manipulation of iron involves supplementation to treat deficiency or chelation to manage overload; relevant biomarkers guide patient selection and monitoring[5][8]. However, describing "iron cation" as a therapeutic target is inaccurate because it does not denote a discrete protein or molecular entity, but rather a basic chemical ion with wide cellular and extracellular involvement. Such nomenclature is fundamentally too broad, and so the entry is marked as incorrect for a precise molecular target. Key references: - Iron in metabolism and regulation[2][5][6][8] - Chemical speciation and biological forms[1][7][10] - Clinical uses: anemia management, chelation[5][8] If specific targets related to iron (e.g., Transferrin receptor, Divalent metal transporter 1, Ferroportin, etc.) are intended, those should be listed distinctly.
Supplements: replace biological iron stores to permit normal hemoglobin and enzyme function; Chelators: bind and promote excretion of excess iron
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Iron cation (Fe²⁺, Fe³⁺).